Barrington Research Upgrades Conceptus (CPTS) to Outperform
CPTS Hot Sheet
Rating Summary:7 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Barrington Research upgrades Conceptus (Nasdaq: CPTS) to Outperform. Price target $23.
To see more analyst ratings on CPTS Click Here.
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States.
To see more analyst ratings on CPTS Click Here.
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States.
You May Also Be Interested In
- UPDATE: UBS Upgrades Westlake Chemical (WLK) to Neutral; Fairly Valued Now
- UPDATE: Auriga Upgrades Lifepoint Holdings (LPNT) to Buy; Use Recent Pullback As Opportunity
- Barclays Reiterates Cautious Stance on hhgregg (HGG); Lowering PT & Estimates
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
